SDIC
ADMA icon

South Dakota Investment Council’s ADMA Biologics ADMA Stock Holding History

South Dakota Investment Council’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86K Hold
9,500
– – ﹤0.01% 609
2025
Q4 		$173K Hold
9,500
– – ﹤0.01% 572
2025
Q3 		$139K Hold
9,500
– – ﹤0.01% 590
2025
Q2 		$173K Buy
+9,500
New +$194K ﹤0.01% 585

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

South Dakota Investment Council's ADMA Position: Q1 2026 in Review

South Dakota Investment Council held its ADMA Biologics (ADMA) position steady in Q1 2026 at 9,500 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

South Dakota Investment Council first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $173K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • South Dakota Investment Council held 9,500 shares of ADMA Biologics worth $86K as of Q1 2026.
  • South Dakota Investment Council left its ADMA Biologics share count unchanged in Q1 2026.
  • ADMA Biologics made up ﹤0.01% of South Dakota Investment Council's portfolio in Q1 2026, its #609 holding.
  • South Dakota Investment Council first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • South Dakota Investment Council's ADMA Biologics position peaked at $173K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on South Dakota Investment Council's 13F filing for Q1 2026, filed 18 May 2026.